QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NASDAQ:KIN

Kindred Biosciences News Headlines

$5.00
-0.29 (-5.48 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.82
Now: $5.00
$5.19
50-Day Range
$3.29
MA: $4.26
$5.29
52-Week Range
$3.11
Now: $5.00
$11.93
Volume249,432 shs
Average Volume312,957 shs
Market Capitalization$196.84 million
P/E RatioN/A
Dividend YieldN/A
Beta1.14

Headlines

Kindred Biosciences (NASDAQ KIN) News Headlines Today

Source:
DateHeadline
Why Kindred Biosciences Is Trading Higher TodayWhy Kindred Biosciences Is Trading Higher Today
finance.yahoo.com - September 16 at 8:19 PM
Stock Alert: Kindred Biosciences Gains 17%Stock Alert: Kindred Biosciences Gains 17%
nasdaq.com - September 16 at 3:19 PM
Kindreds antibody shows efficacy and mortality benefit against canine parvovirusKindred's antibody shows efficacy and mortality benefit against canine parvovirus
seekingalpha.com - September 16 at 10:18 AM
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal AntibodyKindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody
finance.yahoo.com - September 16 at 10:18 AM
Kindred Biosciences (NASDAQ:KIN) Stock Price Up 5.7%Kindred Biosciences (NASDAQ:KIN) Stock Price Up 5.7%
americanbankingnews.com - September 14 at 9:50 PM
Kindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth ConferenceKindred Biosciences to Participate in H.C. Wainwright Global Investment Conference, Cantor Global Healthcare Conference and Lake Street Best Ideas Growth Conference
finance.yahoo.com - September 9 at 12:28 PM
Kindred Biosciences Inc (NASDAQ:KIN) Given Average Rating of "Buy" by BrokeragesKindred Biosciences Inc (NASDAQ:KIN) Given Average Rating of "Buy" by Brokerages
americanbankingnews.com - September 6 at 2:31 PM
 Analysts Anticipate Kindred Biosciences Inc (NASDAQ:KIN) Will Post Quarterly Sales of $570,000.00 Analysts Anticipate Kindred Biosciences Inc (NASDAQ:KIN) Will Post Quarterly Sales of $570,000.00
americanbankingnews.com - September 5 at 4:08 AM
Kindred Biosciences Inc (NASDAQ:KIN) Sees Large Drop in Short InterestKindred Biosciences Inc (NASDAQ:KIN) Sees Large Drop in Short Interest
americanbankingnews.com - September 4 at 12:47 AM
Kindred Biosciences Inc (NASDAQ:KIN) Expected to Announce Earnings of -$0.31 Per ShareKindred Biosciences Inc (NASDAQ:KIN) Expected to Announce Earnings of -$0.31 Per Share
americanbankingnews.com - September 3 at 4:12 AM
Kindred Biosciences (NASDAQ:KIN)  Shares Down 8.7% Kindred Biosciences (NASDAQ:KIN) Shares Down 8.7%
americanbankingnews.com - September 1 at 8:23 PM
Jounce Therapeutics rallies on license deal with Gilead, Tracon Pharma follows, I-Mab, Kindred Biosciences among major losersJounce Therapeutics rallies on license deal with Gilead, Tracon Pharma follows, I-Mab, Kindred Biosciences among major losers
seekingalpha.com - September 1 at 12:12 PM
Kindred Biosciences (NASDAQ:KIN) Shares Up 6.1%Kindred Biosciences (NASDAQ:KIN) Shares Up 6.1%
americanbankingnews.com - August 28 at 7:20 PM
Billionaire Israel Englander Goes Big on These 3 Penny StocksBillionaire Israel Englander Goes Big on These 3 Penny Stocks
finance.yahoo.com - August 27 at 5:11 PM
Kindred Biosciences Announces Second Quarter 2020 Financial ResultsKindred Biosciences Announces Second Quarter 2020 Financial Results
finance.yahoo.com - August 6 at 12:23 AM
Kindred Biosciences EPS beats by $0.47, beats on revenueKindred Biosciences EPS beats by $0.47, beats on revenue
seekingalpha.com - August 5 at 7:22 PM
Kindred Biosciences (KIN) Q2 Earnings and Revenues Beat EstimatesKindred Biosciences (KIN) Q2 Earnings and Revenues Beat Estimates
finance.yahoo.com - August 5 at 7:22 PM
LD Micro - Announces Preliminary List of Presenters for the LD 500LD Micro - Announces Preliminary List of Presenters for the LD 500
finance.yahoo.com - August 5 at 9:20 AM
Kindred Biosciences (KIN) Reports Next Week: Wall Street Expects Earnings GrowthKindred Biosciences (KIN) Reports Next Week: Wall Street Expects Earnings Growth
finance.yahoo.com - July 29 at 2:02 PM
Despite Lacking Profits Kindred Biosciences (NASDAQ:KIN) Seems To Be On Top Of Its DebtDespite Lacking Profits Kindred Biosciences (NASDAQ:KIN) Seems To Be On Top Of Its Debt
finance.yahoo.com - July 28 at 7:06 PM
Kindred Biosciences to Announce Second Quarter 2020 Financial ResultsKindred Biosciences to Announce Second Quarter 2020 Financial Results
finance.yahoo.com - July 23 at 1:45 PM
Kindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing PoorKindred Biosciences Announces European Commission Approval of Mirataz® 20 mg/g Transdermal Ointment for Cats Experiencing Poor
www.bloomberg.com - July 20 at 12:45 AM
Kindred Bio (KIN) Upgraded to Buy: Heres WhyKindred Bio (KIN) Upgraded to Buy: Here's Why
www.nasdaq.com - July 8 at 2:45 PM
Kindred Bio (KIN) Upgraded to Buy: Here's WhyKindred Bio (KIN) Upgraded to Buy: Here's Why
finance.yahoo.com - July 8 at 2:45 PM
Is the Options Market Predicting a Spike in Kindred Biosciences (KIN) Stock?Is the Options Market Predicting a Spike in Kindred Biosciences (KIN) Stock?
finance.yahoo.com - June 29 at 1:08 PM
It’s Showtime for This European Cinema Chain’s StockIt’s Showtime for This European Cinema Chain’s Stock
finance.yahoo.com - June 19 at 8:46 AM
Hedge Funds Cautiously Watching Kindred Biosciences Inc (KIN)Hedge Funds Cautiously Watching Kindred Biosciences Inc (KIN)
finance.yahoo.com - June 15 at 12:22 AM
BRIEF-Kindred Biosciences To Reduce Operating Expenditures To About $10 Mln By Q4 2020BRIEF-Kindred Biosciences To Reduce Operating Expenditures To About $10 Mln By Q4 2020
www.reuters.com - June 9 at 12:33 AM
BRIEF-Kindred Biosciences Inc - Expects Restructuring To Be Completed In Q3 2020BRIEF-Kindred Biosciences Inc - Expects Restructuring To Be Completed In Q3 2020
www.reuters.com - June 8 at 7:32 PM
Kindred Bio to downsize in cost-cutting moveKindred Bio to downsize in cost-cutting move
seekingalpha.com - June 8 at 7:32 PM
Co-founder exits Peninsula pet drug maker as it sheds 25 more jobsCo-founder exits Peninsula pet drug maker as it sheds 25 more jobs
www.bizjournals.com - June 8 at 7:32 PM
Kindred Biosciences Announces Plan to Strengthen its Strategic PositionKindred Biosciences Announces Plan to Strengthen its Strategic Position
finance.yahoo.com - June 8 at 7:32 PM
BRIEF-Kindred Biosciences Reports Covid-19 Vaccine Manufacturing Agreement With VaxartBRIEF-Kindred Biosciences Reports Covid-19 Vaccine Manufacturing Agreement With Vaxart
www.reuters.com - May 20 at 11:43 PM
Bay Area Covid vaccine developer picks candidate, another manufacturing partnerBay Area Covid vaccine developer picks candidate, another manufacturing partner
www.bizjournals.com - May 20 at 1:42 PM
Kindred Bio in pact to make Vaxart COVID-19 vaccineKindred Bio in pact to make Vaxart COVID-19 vaccine
seekingalpha.com - May 20 at 8:42 AM
Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws ConferenceKindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference
finance.yahoo.com - May 13 at 8:54 AM
Earnings Release: Heres Why Analysts Cut Their Kindred Biosciences, Inc. (NASDAQ:KIN) Price Target To US$13.93Earnings Release: Here's Why Analysts Cut Their Kindred Biosciences, Inc. (NASDAQ:KIN) Price Target To US$13.93
finance.yahoo.com - May 10 at 12:24 PM
Earnings Release: Here's Why Analysts Cut Their Kindred Biosciences, Inc. (NASDAQ:KIN) Price Target To US$13.93Earnings Release: Here's Why Analysts Cut Their Kindred Biosciences, Inc. (NASDAQ:KIN) Price Target To US$13.93
finance.yahoo.com - May 10 at 12:24 PM
Edited Transcript of KIN earnings conference call or presentation 7-May-20 8:30pm GMTEdited Transcript of KIN earnings conference call or presentation 7-May-20 8:30pm GMT
finance.yahoo.com - May 8 at 5:58 PM
Kindred Biosciences EPS misses by $0.15, misses on revenueKindred Biosciences EPS misses by $0.15, misses on revenue
seekingalpha.com - May 7 at 6:40 PM
BRIEF-Kindred Biosciences Reports Q1 Loss Per Share Of $0.58BRIEF-Kindred Biosciences Reports Q1 Loss Per Share Of $0.58
www.reuters.com - May 7 at 6:40 PM
Kindred Biosciences Announces First Quarter 2020 Financial ResultsKindred Biosciences Announces First Quarter 2020 Financial Results
finance.yahoo.com - May 7 at 6:40 PM
Did Changing Sentiment Drive Kindred Biosciences (NASDAQ:KIN) Share Price Down By 47%?Did Changing Sentiment Drive Kindred Biosciences' (NASDAQ:KIN) Share Price Down By 47%?
finance.yahoo.com - May 2 at 5:24 PM
Did Changing Sentiment Drive Kindred Biosciences' (NASDAQ:KIN) Share Price Down By 47%?Did Changing Sentiment Drive Kindred Biosciences' (NASDAQ:KIN) Share Price Down By 47%?
finance.yahoo.com - May 2 at 5:24 PM
Will Kindred Biosciences (KIN) Report Negative Earnings Next Week? What You Should Know | NasdaqWill Kindred Biosciences (KIN) Report Negative Earnings Next Week? What You Should Know | Nasdaq
www.nasdaq.com - May 2 at 8:06 AM
Kindred Biosciences to Announce First Quarter 2020 Financial ResultsKindred Biosciences to Announce First Quarter 2020 Financial Results
finance.yahoo.com - April 23 at 9:14 AM
Edited Transcript of KIN earnings conference call or presentation 16-Mar-20 8:30pm GMTEdited Transcript of KIN earnings conference call or presentation 16-Mar-20 8:30pm GMT
finance.yahoo.com - March 30 at 8:47 AM
Kindred fusion protein shows positive effect in dogs with atopic dermatitisKindred fusion protein shows positive effect in dogs with atopic dermatitis
seekingalpha.com - March 24 at 1:26 PM
Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsKindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in Dogs
finance.yahoo.com - March 24 at 1:26 PM
Kindred Biosciences, Inc. Just Reported Earnings, And Analysts Cut Their Target PriceKindred Biosciences, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
finance.yahoo.com - March 18 at 7:47 AM
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.